Matthew Mazdyasni's most recent trade in Astrana Health Inc. was a trade of 3,564 Common Stock done . Disclosure was reported to the exchange on Aug. 13, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Astrana Health Inc. | Matthew Mazdyasni | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 3,564 | 8,314 (0%) | 0% | 0 | Common Stock | |
Apollo Medical Holdings Inc | Matthew Mazdyasni | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 4,750 | 4,750 (0%) | 0% | 0 | Common Stock | |
Apollo Medical Holdings Inc | Matthew Mazdyasni | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2022 | 8,500 | 8,500 | - | - | Stock Option (right to buy) | |
Apollo Medical Holdings Inc | Matthew Mazdyasni | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2020 | 20,000 | 20,000 | - | - | Stock Option (right to buy) |